| Date | Title | |
| 12/18/12 | Cytokinetics, Incorporated Announces Listing Transfer from NASDAQ Global Market to NASDAQ Capital Market |  |
| 12/12/12 | Cytokinetics Highlights Progress of Activities Directed to Muscle Biology at Today's Research & Development Day | |
| 12/07/12 | Cytokinetics Announces Presentation of Additional Analyses from Clinical Trials of Tirasemtiv in Patients with Amyotrophic Lateral Sclerosis | |
| 11/29/12 | Cytokinetics to Present Clinical Trial Data Relating to Tirasemtiv in Patients with Amyotrophic Lateral Sclerosis | |
| 11/29/12 | Cytokinetics Announces Opening of Third and Final Cohort in ATOMIC-AHF | |
| 11/28/12 | Cytokinetics to Host Research and Development Day on Wednesday, December 12, 2012 | |
| 11/07/12 | Cytokinetics to Present at the Lazard 9th Annual Healthcare Conference | |
| 10/30/12 | Cytokinetics, Incorporated Reports Third Quarter 2012 Financial Results | |
| 10/29/12 | Cytokinetics Announces Opening of BENEFIT-ALS, A Phase IIb Clinical Trial of Tirasemtiv (CK-2017357) in Patients with Amyotrophic Lateral Sclerosis | |
| 10/23/12 | Cytokinetics, Inc. : Cytokinetics to Announce Third Quarter Results on October 30, 2012 | |
| 09/24/12 | Cytokinetics Announces Its Participation in the Launch of MyoKardia Through a Research Collaboration Directed to Hypertrophic Cardiomyopathies | |
| 09/11/12 | Cytokinetics Congratulates Its Founders, James A. Spudich, Ph.D. and Ronald D. Vale, Ph.D., on their Receipt of the 2012 Lasker Award for Basic Medical Research | |
| 09/10/12 | Cytokinetics Prepares to Initiate Registration Program for Tirasemtiv (CK-2017357) in Amyotrophic Lateral Sclerosis Following Recent Regulatory Interactions | |
| 09/04/12 | Cytokinetics to Present at The Rodman & Renshaw Global Investment Conference | |
| 07/31/12 | Cytokinetics, Incorporated Reports Second Quarter 2012 Financial Results | |
| 07/26/12 | Cytokinetics Announces Heart Failure Program Update | |
| 07/24/12 | Cytokinetics to Announce Second Quarter Results on July 31, 2012 | |
| 07/05/12 | Cytokinetics to Present at 7th Annual JMP Securities Healthcare
Conference | |
| 06/20/12 | Cytokinetics, Incorporated Announces $60 Million Financing | |
| 06/19/12 | Cytokinetics Announces Proposed Public Offerings of Common Stock and
Warrants and Series B Convertible Preferred Stock and Warrants | |
| 06/19/12 | Cytokinetics, Incorporated Receives NASDAQ Notice of Minimum Bid
Price Non-Compliance | |
| 06/12/12 | Cytokinetics Announces Publication of Phase II Evidence of Effect
Study of CK-2017357 in the Journal Amyotrophic Lateral Sclerosis | |
| 05/24/12 | Cytokinetics Announces Opening of Second Cohort in Phase IIb Clinical
Trial of Intravenous Omecamtiv Mecarbil in Patients With Acute Heart
Failure | |
| 05/15/12 | Cytokinetics to Hold Annual Meeting of Stockholders | |
| 05/09/12 | Cytokinetics Announces Company Participation and Support of ALS
Fundraising Activities in Connection With ALS Awareness Month | |
| 04/26/12 | Cytokinetics, Incorporated Reports First Quarter 2012 Financial
Results | |
| 04/26/12 | Cytokinetics Announces Presentation of Preclinical Data Regarding
CK-2017357 at the 2012 Experimental Biology Annual Conference | |
| 04/25/12 | Cytokinetics Announces Encouraging Results From Two Phase II Clinical
Trials Evaluating CK-2017357 in Patients With Amyotrophic Lateral
Sclerosis | |
| 04/19/12 | Cytokinetics to Announce First Quarter Results on April 26, 2012 | |
| 04/19/12 | Cytokinetics Announces CK-2017357 Receives Fast Track Designation
From the FDA for the Potential Treatment of Amyotrophic Lateral
Sclerosis | |
| 04/18/12 | Cytokinetics Announces Clinical Trial Data Relating to CK-2017357 to
Be Presented at the 64th Annual Meeting of the American Academy of
Neurology | |
| 03/27/12 | Cytokinetics to Present at the Eleventh Annual Needham Life Sciences
Conference | |
| 03/07/12 | Cytokinetics Announces Changes to Its Board of Directors | |
| 03/06/12 | Cytokinetics Announces That the European Medicines Agency Has Granted
CK-2017357 Orphan Medicinal Product Designation for the Treatment of
Amyotrophic Lateral Sclerosis | |
| 03/05/12 | Cytokinetics Announces Fundamental Research in the Field of Fast
Skeletal Muscle Activation Published in the Journal Nature Medicine | |
| 02/28/12 | Cytokinetics to Present at March Healthcare Conferences | |
| 02/21/12 | Cytokinetics Announces Initiation of Phase I Clinical Trial of Oral
Formulations of Omecamtiv Mecarbil in Healthy Volunteers | |
| 02/06/12 | Cytokinetics to Present at BIO CEO and Investor Conference | |
| 02/02/12 | Cytokinetics, Incorporated Reports Fourth Quarter and Year End
Highlights and 2011 Financial Results | |
| 01/26/12 | Cytokinetics to Announce Fourth Quarter and Year End Results on February 2, 2012 | |
